Literature DB >> 17915812

In vitro dissolution method for evaluation of buprenorphine in situ gel formulation: a technical note.

Richard A Graves1, Thomas Freeman, Tarun K Mandal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17915812     DOI： 10.1208/pt0803062

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN： 1530-9932            Impact factor:   3.246


× No keyword cloud information.
  4 in total

1.  Preparation and in vitro evaluation of injectable formulations of levothyroxine sodium using in situ forming hydrogel temperature-responsive systems based on PLA-PEG-PLA and PLGA-PEG-PLGA triblock copolymers.

Authors:  Jebraeil Movaffagh; Farzin Hadizadeh; Elham Khodaverdi; Bahnaz Khalili; Seyedeh Nesa Rezaeian Shiadeh; Hossein Kamali; Fatemeh Oroojalian
Journal:  Iran J Basic Med Sci       Date:  2022-03       Impact factor: 2.532

2.  Evaluation of buprenorphine hydrochloride Pluronic(®) gel formulation in male C57BL/6NCrl mice.

Authors:  Terry L Blankenship-Paris; John W Dutton; David R Goulding; Christopher A McGee; Grace E Kissling; Page H Myers
Journal:  Lab Anim (NY)       Date:  2016-09-21       Impact factor: 12.625

3.  Development of an enhanced formulation for delivering sustained release of buprenorphine hydrochloride.

Authors:  S Koocheki; S S Madaeni; P Niroomandi
Journal:  Saudi Pharm J       Date:  2011-05-12       Impact factor: 4.330

4.  In Situ-Forming Microparticles for Controlled Release of Rivastigmine: In Vitro Optimization and In Vivo Evaluation.

Authors:  Mohamed Haider; Ibrahim Elsayed; Iman S Ahmed; Ahmed R Fares
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.